abstract |
The invention relates to a method of treating a disease associated with motor neurons in a person in need thereof, comprising administering to the person a therapeutically effective amount of a composition comprising a LINGO-2 antagonist, wherein the LINGO-2 antagonist is a LINGO-2 antibody or its antigen binding fragment, which predominantly binds to lingo-2. |